Switch to:
More From Other Websites
Biotechs Weaken, But These Names Have Bullish Charts Nov 25 2015
Amgen applies to FDA for competitor drug to AbbVie's Humira Nov 25 2015
Amgen files for U.S. approval of biosimilar to Humira Nov 25 2015
4:01 pm Amgen submits a Biologics License Application with the FDA for ABP 501, a biosimilar to... Nov 25 2015
Amgen's First Biosimilar Biologics License Application For ABP 501 Submitted To U.S. Food And Drug... Nov 25 2015
Biotech Stock Roundup: KaloBios Soars as Shkreli Steps In, FDA Panel Not Convinced about BioMarin... Nov 25 2015
Short Sellers Run for Cover From Major Biotechs Nov 25 2015
Amgen Gained as CVS Sealed the Deal to Sell Repatha Nov 24 2015
Hedge Fund Favorite: GILD Nov 24 2015
Amgen's Repatha Gets Preferred Position on CVS Formularies Nov 24 2015
European Commission Approves Amgen's BLINCYTO® (blinatumomab) for the Treatment of Adults with... Nov 24 2015
Will Celgene Raise Its 2020 Outlook? Nov 23 2015
CVS' Amgen Pick 'Raises The Bar' For Regeneron, Sanofi Nov 23 2015
Amgen (AMGN) Stock Rises on CVS Health Partnership Nov 23 2015
Uh Oh, CVS Prefers Amgen's Cholesterol Drug to Regeneron's Nov 23 2015
CVS Chooses New Cholesterol Drug for Caremark Nov 23 2015
Amgen Announces Repatha® Preferred Position On CVS Health Commercial Formularies Nov 23 2015
CVS chooses Amgen's new cholesterol drug over competitor Nov 23 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership